Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

One Year After Vioxx, Pendulum May Be Swinging Back To Efficacy At FDA

Oct 10 2005

• By The Pink Sheet

Related Content

IoM Drug Safety Study May Buy Time For FDA; Report Will Play In PDUFA IV

Nov 15 2004

FDA "Drug Watch" Listing Removal Criteria Need Greater Clarity - PhRMA

Aug 15 2005

FDA Office Of Drug Safety Director Could Be Named By Late Summer

Jul 04 2005

FDA Unveils Rx Safety Board, Website; Postmarket Surveillance Overhaul Next

Feb 21 2005

FDA Public Meeting On Rx Risk, Benefit Communication Slated For December

Sep 19 2005

FDA Postmarketing Surveillance System Adds Kaiser Retrospective Database

Oct 03 2005

FDA Drug Safety Office Needs Better System To Track Recommendations

Jul 25 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window